Neural Mechanisms Underlying the Auditory Phenotype of Mild Traumatic Brain Injury
轻度创伤性脑损伤听觉表型背后的神经机制
基本信息
- 批准号:10531215
- 负责人:
- 金额:$ 18.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-12-01 至 2025-11-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAnatomyAnimal ModelAnosmiaAreaAuditoryAuditory PsychophysicsAuditory areaAuditory systemAwardAwarenessBehavioralBiological MarkersBrainBrain ConcussionClassificationClinicalCoalCochleaCodeCompensationCraniocerebral TraumaCuesDevelopmentDiagnosisDiagnostic ProcedureDiseaseDizzinessElectroencephalographyEtiologyExhibitsFrequenciesFunctional disorderFutureGenetic TranscriptionGoalsHearingHearing TestsHearing problemHistopathologyHumanHyperactivityHyperacusisImaging technologyIndividualInferior ColliculusInjuryInner Hair CellsLinkLiquid substanceLiteratureMeasurementMeasuresMentorsMentorshipMessenger RNAModalityModelingMusNeurobiologyNeuronsNeuropathyPathologyPathway interactionsPatient Self-ReportPatient observationPatientsPhenotypePhysiologicalPsychophysicsPublic HealthReportingResearchScalp structureScientistSensorySerinusSeveritiesSignal TransductionSourceSpeech IntelligibilityStimulusStructureSymptomsSynapsesSystemTechnologyTestingTimeTinnitusTrainingTraumatic Brain InjuryUnited StatesVisionauditory pathwayclinical imagingcommon symptomcomparison controldisabilityexperienceextracellularhearing impairmenthuman subjectinsightmechanical forcemild traumatic brain injurymouse modelneuralneurobiological mechanismneuromechanismneurophysiologyneurosensorynovel strategiespsychosocialresearch clinical testingresponsesensory systemsoundspeech in noisestimulus processing
项目摘要
PROJECT SUMMARY / ABSTACT
Mild traumatic brain injury (mTBI) is a major global public health issue. Following mTBI, individuals commonly
report difficulties with hearing quality, tinnitus, hyperacusis, and speech-in-noise intelligibility. In order to
understand why patients experience auditory dysfunction after mTBI, new approaches are needed that combine
quantitative non-invasive biomarkers in mTBI patients with studies of the underlying neurophysiological and
anatomical changes. The overarching hypothesis of the proposal is that many of the neurosensory disorders
associated with mTBI share a common root related to a disruption of low-level sensory feature coding. Of all the
sensory systems, the auditory system places the highest demand on rapid, high-fidelity temporal coding. We
therefore propose that abnormal temporal processing and central gain in the auditory system of mTBI patients
and animal models would highlight a neural signature of the auditory behavioral sequalae and may serve as the
“canary in the coal mine” for distributed pathophysiology occurring more generally in other brain systems. Thus,
the Candidate proposes a mentored training plan to develop non-invasive biomarkers of auditory dysfunction in
mTBI subjects and to identify the neurobiological substrates for these deficits in a mouse model of mTBI.
The Candidate has assembled a mentorship team that has expertise in a range of relevant areas for the
proposal, including psychophysics in human subjects, mTBI mouse models, neurophysiological measures of
auditory temporal processing and central gain, and quantitative cochlear histopathology. By integrating
complementary levels of analysis through the study of different species it will be possible to generate greater
insight into the pathophysiology of mTBI. In Aim 1, the Candidate will use a combination of auditory
psychophysical tests and measures of the electroencephalography (EEG) frequency following response to test
the hypothesis that mTBI subjects show deficits in coding rapid temporal cues and hyperactivity in sound intensity
coding relative to controls. In Aim 2, the Candidate will incorporate a mouse mTBI model to compare EEG
recordings against extracellular recordings of local field potentials and single unit spiking from the inferior
colliculus (IC) and auditory cortex (ACtx) to test whether: 1) mice exhibit a similar auditory temporal processing
and central gain phenotype observed in human subjects, and 2) abnormal temporal processing and coding of
sound intensity are more prevalent in the IC or ACtx. In Aim 3, the Candidate will examine sensory and neural
pathology in the cochlea of mice that have undergone mTBI, as well as transcriptional changes in Gria2 and
Gabra1 mRNA levels in the IC and ACtx. These studies in Aim 3 will address the hypothesis that dysregulation
of auditory temporal processing and central gain are linked to cochlear afferent neuropathy and imbalanced
markers of excitatory and inhibitory signaling in the central auditory pathway. The K08 award will be a crucial
stepping-stone toward the goal of developing into an independent clinician-scientist.
项目概要/摘要
轻度创伤性脑损伤 (mTBI) 是继 mTBI 之后的一个重大全球公共卫生问题。
报告听力质量、耳鸣、听力过敏和噪声中语音清晰度方面的困难。
为什么患者在 mTBI 后会出现听觉功能障碍,需要新的方法来结合
通过研究潜在的神经生理学和 mTBI 患者的非侵入性生物标志物
该提案的总体假设是许多神经感觉障碍。
与 mTBI 相关的疾病有一个共同的根源,即低级感觉特征编码的破坏。
与感觉系统相比,听觉系统对快速、高保真时间编码的要求最高。
因此提出 mTBI 患者听觉系统的时间处理和中枢增益异常
动物模型将突出行为行为后遗症的神经特征,并可能作为
“煤矿里的金丝雀”对于分布式病理生理学来说更普遍地发生在其他大脑系统中。
候选人提出了一项指导培训计划,以开发听觉功能障碍的非侵入性生物标志物
mTBI 受试者并确定 mTBI 小鼠模型中这些缺陷的神经生物学基础。
候选人组建了一个导师团队,该团队在一系列相关领域拥有专业知识
提案,包括人类受试者的心理物理学、mTBI 小鼠模型、神经生理学测量
听觉时间处理和中枢增益,以及定量耳蜗组织病理学。
通过对不同物种的研究进行互补水平的分析将有可能产生更大的结果
深入了解 mTBI 的病理生理学 在目标 1 中,考生将结合听觉。
心理物理测试和测试反应后脑电图 (EEG) 频率的测量
假设 mTBI 受试者在编码快速时间线索方面表现出缺陷,并且在声音强度方面表现出过度活跃
在目标 2 中,候选人将结合小鼠 mTBI 模型来比较脑电图。
针对局部场电位的细胞外记录和来自下层的单个单元尖峰的记录
丘 (IC) 和听觉皮层 (ACtx) 来测试是否:1) 小鼠表现出类似的听觉时间处理
和在人类受试者中观察到的中心增益表型,以及2)异常的时间处理和编码
声音强度在 IC 或 ACtx 中更为普遍 在目标 3 中,考生将检查感觉和神经。
经历过 mTBI 的小鼠耳蜗的病理学,以及 Gria2 和
IC 和 ACtx 中的 Gabra1 mRNA 水平。目标 3 中的这些研究将解决失调的假设。
听觉时间处理和中枢增益的降低与耳蜗传入神经病变和不平衡有关
K08 奖将是一个至关重要的奖项。
迈向发展成为独立临床医生科学家目标的踏脚石。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elliott Kozin其他文献
Elliott Kozin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elliott Kozin', 18)}}的其他基金
Neural Mechanisms Underlying the Auditory Phenotype of Mild Traumatic Brain Injury
轻度创伤性脑损伤听觉表型背后的神经机制
- 批准号:
10862947 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别:
Neural Mechanisms Underlying the Auditory Phenotype of Mild Traumatic Brain Injury
轻度创伤性脑损伤听觉表型背后的神经机制
- 批准号:
10295788 - 财政年份:2020
- 资助金额:
$ 18.61万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Novel Implementation of Microporous Annealed Particle HydroGel for Next-generation Posterior Pharyngeal Wall Augmentation
用于下一代咽后壁增强的微孔退火颗粒水凝胶的新实现
- 批准号:
10727361 - 财政年份:2023
- 资助金额:
$ 18.61万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 18.61万 - 项目类别:
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
- 批准号:
10759550 - 财政年份:2023
- 资助金额:
$ 18.61万 - 项目类别:
Dissecting stress modulation of pnVTA nociceptin peptide-mediated approach-avoidance behavior
剖析 pnVTA 伤害感受肽介导的趋避行为的应激调节
- 批准号:
10676589 - 财政年份:2023
- 资助金额:
$ 18.61万 - 项目类别:
Development of the waixenicin A pharmacophore as a therapeutic intervention for neonatal hypoxic brain injury
开发 Waixenicin A 药效团作为新生儿缺氧性脑损伤的治疗干预措施
- 批准号:
10577489 - 财政年份:2023
- 资助金额:
$ 18.61万 - 项目类别: